Project Grant HT94252310859
Award Date
8/15/23
Completion Date
8/14/26
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
The University of Pennsylvania has been awarded a $1,300,003 Cooperative Agreement by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to serve as a clinical trial site for the Kidney Cancer Research Consortium. The award, which runs from September 15, 2024 to September 14, 2028, will support the university's research focused on advancing kidney cancer treatments. As a leading academic medical center, the University of Pennsylvania will leverage...
This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
The Trustees of the University of Pennsylvania were awarded a $299,099 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Metabolic Target Identification in Age-Associated B Cells from May 1, 2023 through April 30, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health care through innovative medical research, this...
The U.S. Department of the Army Medical Command awarded a $2,027,311 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research will explore innovative approaches to...
The Trustees of the University of Pennsylvania will receive $568,750 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 1, 2022 to June 30, 2025 to develop treatment of chondrosarcoma, a type of bone cancer, using YAP siRNA nanoparticles in a novel mouse model of chondrosarcoma. The Military Medical Research and Development program (CFDA 12.420) supports basic, applied,...
This $188,000 Project Grant was awarded on April 1, 2024 by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to The Institute For Cancer Research. The grant funds a research project titled "P2X7 RECEPTOR AS A NOVEL THERAPEUTIC TARGET IN PROSTATE CANCER" that will be conducted from April 1, 2024 through March 31, 2026. The Institute For Cancer Research, a non-profit subsidiary of Temple University, will carry out biomedical research...
This $1,044,720 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research by Brigham & Women's Hospital, a subsidiary of Partners Healthcare System, to develop targeting kits using mono- and bi-paratopic antibody drug conjugates for chromophobe renal cell carcinoma. The award has an initial performance period from August 1, 2024 to July 31, 2027. The objective is to advance innovative therapeutic...
This federal Project Grant award of $946,873.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports genetic research on prostate cancer risk in self-identified Black veterans. The grant was awarded on July 1, 2025 to The Trustees of the University of Pennsylvania, who will conduct the research through their Clinical Practices of the University of Pennsylvania division. The project aims to advance understanding of the genetic factors...